FierceBiotech 2026年4月9日 Judge rules that HHS must face states' lawsuit over RFK Jr.'s agency overhaul, massive layoffs
FierceBiotech 2026年4月9日 'It’s going to be huge': The 'diabolical' molecule poised to become biotech's next gold rush
FierceBiotech 2026年4月9日 Gilead pays Kymera $45M to glue preclinical protein degrader onto burgeoning oncology pipeline
FierceBiotech 2026年4月9日 Boehringer hands over funding, marketing rights for Click’s digital therapeutic
FierceBiotech 2026年4月9日 In a first, a CAR-T cell therapy drives 3 autoimmune diseases into remission in a single patient
FierceBiotech 2026年4月9日 Avalyn plans IPO to fund phase 3 trials of inhaled versions of approved respiratory drugs
FierceBiotech 2026年4月9日 Roche takes 'leap of faith' with $20M bet on C4T’s antibody-targeted protein degraders
FierceBiotech 2026年4月8日 Medline hit with FDA warning letter over defective heart syringes, safety hazards
FierceBiotech 2026年4月8日 Artivion nabs PMA clearance for aortic stent graft system, triggers Endospan buyout option
FierceBiotech 2026年4月8日 With $2B Novo deal in the books, Vivtex isn't 'limited to being just a drug delivery company': CEO
FierceBiotech 2026年4月8日 Akari locks arms with WuXi XDC to develop and manufacture novel ADC treatment
FierceBiotech 2026年4月8日 Jeito hails $1.2B as 'largest raise ever' for independent biopharma-focused European fund
FierceBiotech 2026年4月8日 OrbiMed’s Sidewinder slides toward clinic with $137M series B for antibody-drug conjugates
FierceBiotech 2026年4月8日 With 3 acquisitions to digest, Gilead shifts focus from M&A to pipeline that has 'never been stronger'
FierceBiotech 2026年4月7日 Lilly pays AC Immune $12.5M to expand Alzheimer’s collab as asset draws closer to clinic